Editor in Chief / Deputy Editor ( Immunology)
John Wiley & Sons Inc. | |
United States, New Jersey, Hoboken | |
111 River Street (Show on map) | |
Jan 14, 2026 | |
|
Job Description: Editor in Chief / Deputy Editor ( Immunology)Location: Beijing, CHNOur mission is to unlock human potential. We welcome you for who you are, the background you bring, and we embrace individuals who get excited about learning. Bring your experiences, your perspectives, and your passion; it's in our differences that we empower the way the world learns. About the Role: About the Role: We are seeking a highly motivated and strategic Editor-in-Chief/Deputy Editor to join Wiley's Advanced team, serving as Deputy Editor [Immunology] for our flagship journal, Advanced Science, and Editor-in-Chief of a related Advanced spin-off title. The ideal candidate will be a dedicated Advanced portfolio ambassador with an extensive global network in immunology and translational research, driving strategic initiatives that bridge groundbreaking research communities and shape how interdisciplinary science is published and shared worldwide. The Editor-in-Chief/Deputy Editor actively participates in the peer review process and decision-making for submitted manuscripts while ensuring adoption of best practices and the highest ethical standards in publishing. How you will make an impact:
What we look for:
More about the Job Description: The Editor-in-Chief/Deputy Editor is entrusted with the strategic development and execution of initiatives aimed at growing Wiley's Advanced Portfolio within the disciplines of Immunology and related Life and Health Science disciplines. With an extensive global network, the Editor-in-Chief/Deputy Editor serves as a dedicated ambassador and advocate for Wiley's Advanced Portfolio in the immunology research community. This role is pivotal for the advancement and expansion of a critically important brand, ensuring alignment with and achievement of the company's strategic goals and objectives. The Editor-in-Chief/Deputy Editor is tasked with converting strategic visions into actionable plans, identifying and seizing opportunities to meet the targets set for Research Publishing. In close collaboration with the marketing team, they will devise and implement a range of brand-enhancing events and initiatives aimed at both short-term and long-term success. The Editor-in-Chief/Deputy Editor will concentrate on enriching the content and elevating the brand profile of Advanced Science, effectively directing excess submissions to relevant clusters within Wiley's Life and Health Sciences portfolio. Additionally, the Editor-in-Chief/Deputy Editor will launch one or more new spin off titles in the relevant subjects and oversee the management of the Advanced spin off titles. By actively engaging with research communities, the Editor-in-Chief/Deputy Editor is committed to commissioning high-quality papers, extending the brand's influence, and forging positive, collaborative relationships with leading researchers. They approach their work with an understanding of the needs of both external and internal stakeholders, driving forward initiatives that connect with top-tier research talents. The Editor-in-Chief/Deputy Editor will provide regular updates to the Senior Manager on community engagement efforts and journal development progress. These reports will include evidence of the impact made by the Immunology initiatives and demonstrate the successful delivery of strategic goals for Wiley's Advanced Portfolio. They will also outline programs and strategies designed to attract and retain authors, as well as to enhance the growth of high-quality content within Advanced Science, across the Advanced portfolio, and the related subject clusters. About Wiley: Wiley is a trusted leader in research and learning, our pioneering solutions and services are paving the way for knowledge seekers as they work to solve the world's most important challenges. We are advocates of advancement, empowering knowledge-seekers to transform today's biggest obstacles into tomorrow's brightest opportunities. | |
Jan 14, 2026